keyword
https://read.qxmd.com/read/33514739/the-nuclear-envelope-protein-net39-is-essential-for-muscle-nuclear-integrity-and-chromatin-organization
#21
JOURNAL ARTICLE
Andres Ramirez-Martinez, Yichi Zhang, Kenian Chen, Jiwoong Kim, Bercin K Cenik, John R McAnally, Chunyu Cai, John M Shelton, Jian Huang, Ana Brennan, Bret M Evers, Pradeep P A Mammen, Lin Xu, Rhonda Bassel-Duby, Ning Liu, Eric N Olson
Lamins and transmembrane proteins within the nuclear envelope regulate nuclear structure and chromatin organization. Nuclear envelope transmembrane protein 39 (Net39) is a muscle nuclear envelope protein whose functions in vivo have not been explored. We show that mice lacking Net39 succumb to severe myopathy and juvenile lethality, with concomitant disruption in nuclear integrity, chromatin accessibility, gene expression, and metabolism. These abnormalities resemble those of Emery-Dreifuss muscular dystrophy (EDMD), caused by mutations in A-type lamins (LMNA) and other genes, like Emerin (EMD)...
January 29, 2021: Nature Communications
https://read.qxmd.com/read/33314705/from-diagnosis-to-prognosis-revisiting-the-meaning-of-muscle-isg15-overexpression-in-juvenile-inflammatory-myopathies
#22
JOURNAL ARTICLE
Cyrielle Hou, Chloé Durrleman, Baptiste Periou, Christine Barnerias, Christine Bodemer, Isabelle Desguerre, Pierre Quartier, Isabelle Melki, Gillian I Rice, Mathieu P Rodero, Jean-Luc Charuel, Fréderic Relaix, Brigitte Bader-Meunier, FrançoisJérôme Authier, Cyril Gitiaux
OBJECTIVE: Juvenile idiopathic inflammatory/immune myopathies (IIMs) constitute a highly heterogeneous group of disorders with diagnostic difficulties and prognostic uncertainties. Circulating myositis-specific autoantibodies (MSAs) have been recognized as reliable tools for patient substratification. Considering the key role of type I interferon (IFN) up-regulation in juvenile IIM, we undertook the present study to investigate whether IFN-induced 15-kd protein (ISG-15) could be a reliable biomarker for stratification and diagnosis and to better elucidate its role in juvenile IIM pathophysiology...
June 2021: Arthritis & Rheumatology
https://read.qxmd.com/read/33305167/predictors-of-prognosis-in-type-1-myotonic-dystrophy-dm1-longitudinal-18-years-experience-from-a-single-center
#23
JOURNAL ARTICLE
Marco Mazzoli, Alessandra Ariatti, Gian Carlo Garuti, Virginia Agnoletto, Maurilio Genovese, Manuela Gozzi, Shaniko Kaleci, Alessandro Marchioni, Marcella Malagoli, Giuliana Galassi
The aim of the study was to identify possible predictors of neurological worsening and need of non-invasive ventilation (NIV) in individuals affected by myotonic dystrophy type 1 (DM1), the most common form of adult-onset muscular dystrophy. METHODS: A retrospective observational cohort study was undertaken. Thirty-three patients with genetic diagnosis of DM1 were followed at our Neuromuscular unit in Modena. Abnormal trinucleotide repeat (CTG) expansion of dystrophy protein kinase gene (MDPK) on chromosome 19q 13...
September 2020: Acta Myologica: Myopathies and Cardiomyopathies: Official Journal of the Mediterranean Society of Myology
https://read.qxmd.com/read/33214392/what-is-in-the-myopathy-literature
#24
JOURNAL ARTICLE
David Lacomis
This update begins with muscle manifestations of coronavirus 2019. They may include myalgias and elevations in serum creatine kinase. It is unknown whether there is direct muscle invasion and how often the critically ill have muscle sequelae. Regarding autoimmune myopathies, a retrospective study of statin-induced necrotizing myopathy is covered. A relatively large proportion of patients had normal strength at presentation. Examples of dermatomyositis associated with immune checkpoint inhibitors are provided including one with cytokine storm...
December 2020: Journal of Clinical Neuromuscular Disease
https://read.qxmd.com/read/32651874/predictors-of-respiratory-decline-in-myotonic-dystrophy-type-1-dm1-a-longitudinal-cohort-study
#25
JOURNAL ARTICLE
Marco Mazzoli, Alessandra Ariatti, Giancarlo Garuti, Virginia Agnoletto, Riccardo Fantini, Alessandro Marchioni, Giuliana Galassi
We studied 33 patients affected by juvenile and adult myotonic dystrophy type 1 (DM1). The aim of the study was to assess clinical and laboratory parameters that could predict the requirement of noninvasive ventilation (NIV) in DM1. Secondary outcome was to assess the interplay between genetic profile, muscle impairment severity and presence of cardiac comorbidities.Patients with genetic diagnosis of DM1 were recruited. An abnormal trinucleotide repeat (CTG) expansion of dystrophy protein kinase gene (DMPK) on chromosome 19q13...
February 2021: Acta Neurologica Belgica
https://read.qxmd.com/read/31808555/strength-training-and-aerobic-exercise-training-for-muscle-disease
#26
JOURNAL ARTICLE
Nicoline Bm Voet, Elly L van der Kooi, Baziel Gm van Engelen, Alexander Ch Geurts
BACKGROUND: Strength training or aerobic exercise programmes, or both, might optimise muscle and cardiorespiratory function and prevent additional disuse atrophy and deconditioning in people with a muscle disease. This is an update of a review first published in 2004 and last updated in 2013. We undertook an update to incorporate new evidence in this active area of research. OBJECTIVES: To assess the effects (benefits and harms) of strength training and aerobic exercise training in people with a muscle disease...
December 6, 2019: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/31407859/age-related-cognitive-decline-in-myotonic-dystrophy-type-1-an-11-year-longitudinal-follow-up-study
#27
JOURNAL ARTICLE
Garazi Labayru, Jone Aliri, Miren Zulaica, Adolfo López de Munain, Andone Sistiaga
BACKGROUND: Myotonic dystrophy type 1 (DM1) is an inherited multi-systemic disease involving the central nervous system (CNS) and is consequently characterized by a range of cognitive impairments. However, whether this cognitive profile progresses over time is still a matter of debate. The aim of this study was to longitudinally assess a DM1 sample, in order to compare, for the first time, this progression with that of a control group. Clinical and socio-demographic predictive factors potentially implicated in this possible decline are analysed...
March 2020: Journal of Neuropsychology
https://read.qxmd.com/read/31077250/effect-and-safety-of-treatment-with-ace-inhibitor-enalapril-and-%C3%AE-blocker-metoprolol-on-the-onset-of-left-ventricular-dysfunction-in-duchenne-muscular-dystrophy-a-randomized-double-blind-placebo-controlled-trial
#28
RANDOMIZED CONTROLLED TRIAL
Sven Dittrich, Erika Graf, Regina Trollmann, Ulrich Neudorf, Ulrike Schara, Antje Heilmann, Maja von der Hagen, Brigitte Stiller, Janbernd Kirschner, Robert Dalla Pozza, Wolfgang Müller-Felber, Katja Weiss, Katja von Au, Markus Khalil, Reinald Motz, Christoph Korenke, Martina Lange, Ekkehard Wilichowski, Joseph Pattathu, Friedrich Ebinger, Nicola Wiechmann, Rolf Schröder
BACKGROUND: X-linked Duchenne muscular dystrophy (DMD), the most frequent human hereditary skeletal muscle myopathy, inevitably leads to progressive dilated cardiomyopathy. We assessed the effect and safety of a combined treatment with the ACE-inhibitor enalapril and the β-blocker metoprolol in a German cohort of infantile and juvenile DMD patients with preserved left ventricular function. METHODS TRIAL DESIGN: Sixteen weeks single-arm open run-in therapy with enalapril and metoprolol followed by a two-arm 1:1 randomized double-blind placebo-controlled treatment in a multicenter setting...
May 10, 2019: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/30552836/muscle-expression-of-type-i-and-type-ii-interferons-is-increased-in-juvenile-dermatomyositis-and-related-to-clinical-and-histological-features
#29
JOURNAL ARTICLE
Gian Marco Moneta, Denise Pires Marafon, Emiliano Marasco, Silvia Rosina, Margherita Verardo, Chiara Fiorillo, Carlo Minetti, Luisa Bracci-Laudiero, Angelo Ravelli, Fabrizio De Benedetti, Rebecca Nicolai
OBJECTIVES: Our aim was to evaluate expression of type I interferon (IFNα/β)- and type II IFN (IFNγ)-inducible genes in muscle biopsies of JDM patients and to correlate their expression levels with histological and clinical features. METHODS: Expression levels of IFN-inducible genes and pro-inflammatory cytokines were assessed by quantitative PCR in muscle biopsies of JDM patients (n = 39), Duchenne muscular dystrophy (DMD) patients (n = 24) and healthy controls (HCs) (n = 4)...
December 15, 2018: Arthritis & Rheumatology
https://read.qxmd.com/read/30352204/serum-biomarkers-of-glucocorticoid-response-and-safety-in-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-and-juvenile-dermatomyositis
#30
JOURNAL ARTICLE
Laurie S Conklin, Peter A Merkel, Lauren M Pachman, Hemang Parikh, Shefa Tawalbeh, Jesse M Damsker, David D Cuthbertson, Gabrielle A Morgan, Paul A Monach, Yetrib Hathout, Kanneboyina Nagaraju, John van den Anker, Carol A McAlear, Eric P Hoffman
Glucocorticoids are standard of care for many chronic inflammatory conditions, including juvenile dermatomyositis (JDM) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We sought to define pharmacodynamic biomarkers of therapeutic efficacy and safety concerns of glucocorticoid treatment for these two disorders. Previous proteomic profiling of patients with Duchenne muscular dystrophy (DMD) and inflammatory bowel disease (IBD) treated with glucocorticoids identified candidate biomarkers for efficacy and safety concerns of glucocorticoids...
December 2018: Steroids
https://read.qxmd.com/read/29610677/potential-association-of-lmna-associated-generalized-lipodystrophy-with-juvenile-dermatomyositis
#31
JOURNAL ARTICLE
Melis Sahinoz, Shafaq Khairi, Ashley Cuttitta, Graham F Brady, Amit Rupani, Rasimcan Meral, Marwan K Tayeh, Peedikayil Thomas, Meredith Riebschleger, Sandra Camelo-Piragua, Jeffrey W Innis, M Bishr Omary, Daniel E Michele, Elif A Oral
Background: Juvenile dermatomyositis (JDM) is an auto-immune muscle disease which presents with skin manifestations and muscle weakness. At least 10% of the patients with JDM present with acquired lipodystrophy. Laminopathies are caused by mutations in the lamin genes and cover a wide spectrum of diseases including muscular dystrophies and lipodystrophy. The p.T10I LMNA variant is associated with a phenotype of generalized lipodystrophy that has also been called atypical progeroid syndrome...
2018: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/29198644/the-diagnostic-usefulness-of-the-negative-electroretinogram
#32
JOURNAL ARTICLE
C Fuente García, J J González-López, F J Muñoz-Negrete, G Rebolleda
The definition of the negative response of the full field electroretinogram is the presence of a b-wave with less amplitude than the a-wave (b/a ratio<1) in the combined response of cones and rods. The presence of this pattern reflects an alteration in the bipolar cells, the Müller cells, or in the transmission of the stimulus from the photoreceptors to the bipolar cells, with preserved photoreceptor function. This finding can be seen bilaterally and symmetrically in different hereditary conditions, such as congenital stationary night blindness, juvenile X-linked retinoschisis, and Duchenne and Becker muscular dystrophies...
March 2018: Archivos de la Sociedad Española de Oftalmología
https://read.qxmd.com/read/29095865/beneficial-effects-of-high-dose-taurine-treatment-in-juvenile-dystrophic-mdx-mice-are-offset-by-growth-restriction
#33
JOURNAL ARTICLE
Jessica R Terrill, Gavin J Pinniger, Keshav V Nair, Miranda D Grounds, Peter G Arthur
Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disease manifested in young boys, for which there is no current cure. We have shown that the amino acid taurine is safe and effective at preventing dystropathology in the mdx mouse model for DMD. This study aimed to establish if treating growing mdx mice with a higher dose of taurine was more effective at improving strength and reducing inflammation and oxidative stress. Mice were treated with a dose of taurine estimated to be 16 g/kg/day, in drinking water from 1-6 weeks of age, after which in vivo and ex vivo muscle strength was assessed, as were measures of inflammation, oxidative stress and taurine metabolism...
2017: PloS One
https://read.qxmd.com/read/28686329/juvenile-onset-generalized-lipodystrophy-due-to-a-novel-heterozygous-missense-lmna-mutation-affecting-lamin-c
#34
JOURNAL ARTICLE
Nivedita Patni, Chao Xing, Anil K Agarwal, Abhimanyu Garg
The LMNA gene contains 12 exons and encodes lamins A and C by alternative splicing within exon 10. While mutations in lamin A specific residues cause several diseases including lipodystrophy, progeria, muscular dystrophy, neuropathy, and cardiomyopathy, only three families with mutations in lamin C-specific residues are reported with cardiomyopathy, neuropathy, and muscular dystrophy so far. We now report two brothers with juvenile-onset generalized lipodystrophy due to a lamin C-specific mutation. The proband, a 23-year-old Caucasian male was reported to have generalized lipodystrophy at 3 weeks of age, developed diabetes, hypertriglyceridemia, hypertension and liver problems and died with complications of cirrhosis, and kidney failure...
September 2017: American Journal of Medical Genetics. Part A
https://read.qxmd.com/read/28663002/autoantibodies-in-juvenile-onset-myositis-their-diagnostic-value-and-associated-clinical-phenotype-in-a-large-uk-cohort
#35
JOURNAL ARTICLE
Sarah L Tansley, Stefania Simou, Gavin Shaddick, Zoe E Betteridge, Beverley Almeida, Harsha Gunawardena, Wendy Thomson, Michael W Beresford, Angela Midgley, Francesco Muntoni, Lucy R Wedderburn, Neil J McHugh
OBJECTIVES: Juvenile myositis is a rare and heterogeneous disease. Diagnosis is often difficult but early treatment is important in reducing the risk of associated morbidity and poor outcomes. Myositis specific autoantibodies have been described in both juvenile and adult patients with myositis and can be helpful in dividing patients into clinically homogenous groups. We aimed to explore the utility of myositis specific autoantibodies as diagnostic and prognostic biomarkers in patients with juvenile-onset disease...
November 2017: Journal of Autoimmunity
https://read.qxmd.com/read/27796757/targeted-next-generation-sequencing-reveals-novel-ttn-mutations-causing-recessive-distal-titinopathy
#36
JOURNAL ARTICLE
Anni Evilä, Johanna Palmio, Anna Vihola, Marco Savarese, Giorgio Tasca, Sini Penttilä, Sara Lehtinen, Per Harald Jonson, Jan De Bleecker, Peter Rainer, Michaela Auer-Grumbach, Jean Pouget, Emmanuelle Salort-Campana, Juan J Vilchez, Nuria Muelas, Montse Olive, Peter Hackman, Bjarne Udd
Tibial muscular dystrophy (TMD) is the first described human titinopathy. It is a mild adult-onset slowly progressive myopathy causing weakness and atrophy in the anterior lower leg muscles. TMD is caused by mutations in the last two exons, Mex5 and Mex6, of the titin gene (TTN). The first reported TMD mutations were dominant, but the Finnish founder mutation FINmaj, an 11-bp insertion/deletion in Mex6, in homozygosity caused a completely different severe early-onset limb-girdle muscular dystrophy 2J (LGMD2J)...
November 2017: Molecular Neurobiology
https://read.qxmd.com/read/27679740/increased-taurine-in-pre-weaned-juvenile-mdx-mice-greatly-reduces-the-acute-onset-of-myofibre-necrosis-and-dystropathology-and-prevents-inflammation
#37
JOURNAL ARTICLE
Jessica R Terrill, Miranda D Grounds, Peter G Arthur
BACKGROUND: The mdx mouse model for the fatal muscle wasting disease Duchenne Muscular Dystrophy (DMD) shows a very mild pathology once growth has ceased, with low levels of myofibre necrosis in adults. However, from about 3 weeks of post-natal age, muscles of juvenile mdx mice undergo an acute bout of severe necrosis and inflammation: this subsequently decreases and stabilises to lower adult levels by about 6 weeks of age. Prior to the onset of this severe dystropathology, we have shown that mdx mice are deficient in the amino acid taurine (potentially due to weaning), and we propose that this exacerbates myofibre necrosis and inflammation in juvenile mdx mice...
April 29, 2016: PLoS Currents
https://read.qxmd.com/read/27354222/stroke-in-duchenne-muscular-dystrophy-a-retrospective-longitudinal-study-in-54-patients
#38
JOURNAL ARTICLE
Martin Winterholler, Christian Holländer, Frank Kerling, Irina Weber, Sven Dittrich, Matthias Türk, Rolf Schröder
BACKGROUND AND PURPOSE: Duchenne muscular dystrophy (DMD) is the most frequent skeletal muscle myopathy. Nearly all patients develop cardiomyopathy in their second decade of life. The purpose of this study was to evaluate the frequency, cause, and outcome of stroke in a German cohort of patients with DMD. METHODS: Retrospective analysis of medical records of 54 DMD patients, who lived in a regional facility for handicapped people (Wichernhaus Altdorf, Germany) between 1963 and 2013...
August 2016: Stroke; a Journal of Cerebral Circulation
https://read.qxmd.com/read/27022509/limping-in-children
#39
JOURNAL ARTICLE
Cláudio Santili, Wilson Lino Júnior, Ellen de Oliveira Goiano, Romero Antunes Barreto Lins, Gilberto Waisberg, Susana Dos Reis Braga, Miguel Akkari
Limping in children is a common complaint at pediatric, pediatric orthopaedic offices and in emergency rooms. There are several causes for this condition, and identifying them is a challenge. The older the patient, the better the anamnesis and more detailed the physical examination will be, enabling an easier medical assessment for searching the source of the disorder. In order to make the approach easier, three age groups can and should be considered. Among infants (1 to 3 years old), diagnosis will most likely be: transitory synovitis, septic arthritis, neurological disorders (mild brain palsy (BP) and muscular dystrophy), congenital hip dislocation (CHD), varus thigh, juvenile rheumatoid arthritis (JRA) and neoplasias (osteoid osteoma, leukemia); in the scholar age group, between 4 and 10 years old, in addition to the diagnoses above, Legg-Calvé-Perthes disease, discoid meniscus, inferior limbs discrepancy and unspecific muscular pain; in adolescents (11 to 15 years old): slipped capital femoral epiphysis, congenital hip dislocation, chondrolysis, overuse syndromes, dissecans osteochondritis, and tarsal coalition...
January 2009: Revista Brasileira de Ortopedia
https://read.qxmd.com/read/26581302/a-new-titinopathy-childhood-juvenile-onset-emery-dreifuss-like-phenotype-without-cardiomyopathy
#40
JOURNAL ARTICLE
Rafael De Cid, Rabah Ben Yaou, Carinne Roudaut, Karine Charton, Sylvain Baulande, France Leturcq, Norma Beatriz Romero, Edoardo Malfatti, Maud Beuvin, Anna Vihola, Audrey Criqui, Isabelle Nelson, Juliette Nectoux, Laurène Ben Aim, Christophe Caloustian, Robert Olaso, Bjarne Udd, Gisèle Bonne, Bruno Eymard, Isabelle Richard
OBJECTIVE: To identify the genetic defects present in 3 families with muscular dystrophy, contractures, and calpain 3 deficiency. METHODS: We performed targeted exome sequencing on one patient presenting a deficiency in calpain 3 on Western blot but for which mutations in the gene had been excluded. The identification of a homozygous truncating mutation in the M-line part of titin prompted us to sequence this region in 2 additional patients presenting similar clinical and biochemical characteristics...
December 15, 2015: Neurology
keyword
keyword
99667
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.